Seer (SEER) Tariff Resilience Score: 8/10 (As of Jul. 03, 2026)


SEER Seer Inc SEER
53 GF Score
Price $1.62
GF Value $2.20
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Seer Tariff Resilience Score?

Seer SEER -0.61% 53 Tariff Resilience Score is 8 as of Jul. 03, 2026. GuruFocus rates SEER with a GF Score™ of 53/100 and a GF Value™ of $2.20 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,373 Biotechnology companies, Seer ranks better than 98.69% on this metric.

Seer has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Seer has Seer Inc benefits from a strong domestic market focus and minimal reliance on international supply chains. Its industry is less affected by tariffs, and it has the flexibility to adjust pricing if needed.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Seer might have Highly Resilient.

Seer  (NAS:SEER) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Seer Tariff Resilience Score Related Terms

SEER vs CSBR, RLYB, FBIO: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Seer's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Seer Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Seer's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Seer's Tariff Resilience Score falls into.


SEER
53GF Score
Seer Inc SEER
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Seer (SEER) has a Tariff Resilience Score of 8 as of Jul. 03, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Seer ranks #18 out of 1373 companies in the Biotechnology industry, placing it in the top 1.3%.
Is Seer's Tariff Resilience Score too high?
Seer's current Tariff Resilience Score is 8. The Biotechnology industry median Tariff Resilience Score is 4.00. Seer's value of 8 is 100% above this industry median. Based on the distribution chart, Seer ranks #18 out of 1373 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Seer has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Seer's Tariff Resilience Score compare to CSBR and RLYB?
According to the Biotechnology industry distribution chart, Seer ranks #18 out of 1373 companies for Tariff Resilience Score. This places Seer in the top 1% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Seer's value of 8 is 100% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,373 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Seer's current Tariff Resilience Score of 8 is 100% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Seer's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seer stock overvalued right now?
Based on GuruFocus' analysis, Seer (SEER) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.20, compared to a current price of $1.62 — trading 26.4% below its estimated fair value. The current Tariff Resilience Score is 8 and 100% above the Biotechnology industry median of 4.00. Seer's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Seer (SEER), the current Tariff Resilience Score is 8 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Seer (SEER) Overvalued in 2026?

Based on GuruFocus' analysis, Seer stock appears to be undervalued. The current stock price of $1.62 is trading 26.4% below its estimated GF Value™ of $2.20. GuruFocus considers Seer to be Modestly Undervalued.

Key valuation signals for SEER:

  • Tariff Resilience Score: 8
  • GF Value™: $2.20 vs. price of $1.62 (26.4% below fair value)
  • GF Score™: 53/100 with 3 warning signs
  • Industry Position: 100% above the Biotechnology median (#18 of 1373)

No single metric tells the full story. See the SEER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Seer Business Description

Address 3800 Bridge Parkway, Suite 102, Redwood City, CA, USA, 94065
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
53GF Score

Get the complete analysis for SEER

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.62
Price
$2.20
GF Value